AAAAAA

   
Results: 1-9 |
Results: 9
PHASE I II TRIAL OF THE TYPE-I SOLUBLE RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN HIV-1-INFECTED PATIENTS/
Authors: TAKEBE N PAREDES J PINO MC LOWNSBURY WH AGOSTI J KROWN SE
Citation: N. Takebe et al., PHASE I II TRIAL OF THE TYPE-I SOLUBLE RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN HIV-1-INFECTED PATIENTS/, Journal of interferon & cytokine research, 18(5), 1998, pp. 321-326
THE ABSORBENCY DEVIATION METHOD - A SPECTROPHOTOMETRIC ESTIMATION OF THE CRITICAL MICELLE CONCENTRATION (CMC) OF ETHOXYLATED ALKYLPHENOL SURFACTANTS
Authors: YSAMBERTT F VEJAR F PAREDES J SALAGER JL
Citation: F. Ysambertt et al., THE ABSORBENCY DEVIATION METHOD - A SPECTROPHOTOMETRIC ESTIMATION OF THE CRITICAL MICELLE CONCENTRATION (CMC) OF ETHOXYLATED ALKYLPHENOL SURFACTANTS, Colloids and surfaces. A, Physicochemical and engineering aspects, 137(1-3), 1998, pp. 189-196
ASSOCIATION OF LUPUS ANTICOAGULANT WITH ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-FACTOR-II ANTIBODIES
Authors: PAREDES J BALADA E CORTES J VILLARREAL J LABRADOR M MAURI M BUJAN S ORDIROS J
Citation: J. Paredes et al., ASSOCIATION OF LUPUS ANTICOAGULANT WITH ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-FACTOR-II ANTIBODIES, Arthritis and rheumatism, 41(9), 1998, pp. 817-817
ANTI-PHOSPHATIDYLETHANOLAMINE ANTIBODIES AS A MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME
Authors: ORDI J BALADA E MARTINEZ N PAREDES J VILLARREAL J LABRADOR M VILARDELL M
Citation: J. Ordi et al., ANTI-PHOSPHATIDYLETHANOLAMINE ANTIBODIES AS A MARKER FOR THE ANTIPHOSPHOLIPID SYNDROME, Arthritis and rheumatism, 41(9), 1998, pp. 833-833
AUTOANTIBODIES TO C1 INHIBITOR IN PATIENTS WITH LUPUS DISEASE
Authors: ORDIROS J PAREDES J DETARSIO G VILARDELL M
Citation: J. Ordiros et al., AUTOANTIBODIES TO C1 INHIBITOR IN PATIENTS WITH LUPUS DISEASE, Journal of rheumatology, 24(9), 1997, pp. 1856-1858
EARLY IMPRESSIONS OF THE HARMONIC SCALPEL
Authors: PAREDES J BORGES M COULSON A
Citation: J. Paredes et al., EARLY IMPRESSIONS OF THE HARMONIC SCALPEL, Anesthesiology, 85(4), 1996, pp. 947-947
WEEKLY ORAL ETOPOSIDE IN PATIENTS WITH KAPOSIS-SARCOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE-I MULTICENTER TRIALOF THE AIDS CLINICAL-TRIALS GROUP
Authors: PAREDES J KAHN JO TONG WP FELDSTEIN ML LIN SL BENNETT JM METROKA CE RATNER L KROWN SE
Citation: J. Paredes et al., WEEKLY ORAL ETOPOSIDE IN PATIENTS WITH KAPOSIS-SARCOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE-I MULTICENTER TRIALOF THE AIDS CLINICAL-TRIALS GROUP, Journal of acquired immune deficiency syndromes and human retrovirology, 9(2), 1995, pp. 138-144
ANTIFERROMAGNETISM OF SUPERCONDUCTING TB2MO3SI4
Authors: ALIEV FG GORELENKO YK PRYADUN VV VIEIRA S VILLAR R PAREDES J
Citation: Fg. Aliev et al., ANTIFERROMAGNETISM OF SUPERCONDUCTING TB2MO3SI4, Physica. B, Condensed matter, 194, 1994, pp. 171-172
A SUPERCONDUCTING MAGNET - TB2MO3SI4
Authors: ALIEV FG PRYADUN VV VIEIRA S VILLAR R PAREDES J LEVANYUK AP YAROVETS VI
Citation: Fg. Aliev et al., A SUPERCONDUCTING MAGNET - TB2MO3SI4, Europhysics letters, 25(2), 1994, pp. 143-148
Risultati: 1-9 |